U.S. Markets close in 5 hrs 50 mins

Biogen Shores Up Gene Therapy Assets With $800 Million Takeover

ALLISON GATLIN
Biogen Shores Up Gene Therapy Assets With $800 Million Takeover

Nightstar Therapeutics soared early Monday after Biogen pledged to spend $800 million to buy the gene therapy firm. The smaller biotech is working on gene therapies in rare eye diseases.